85176-37-0

Usage

Uses

Used in Chemical Synthesis Industry:
Benzeneethanamine, N-Methyl-4-nitro-, is used as a synthetic intermediate for the production of various compounds. Its highly reactive nature allows it to undergo multiple reactions, making it a valuable component in the synthesis of a wide range of chemical products.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Benzeneethanamine, N-Methyl-4-nitro-, serves as a key intermediate in the synthesis of various pharmaceutical compounds. Its reactivity enables the creation of diverse drug molecules with potential therapeutic applications.
Used in Agrochemical Industry:
Benzeneethanamine, N-Methyl-4-nitro-, is also utilized as a synthetic intermediate in the agrochemical industry for the development of pesticides and other agrochemical products. Its versatility in chemical reactions contributes to the creation of effective and targeted agrochemicals.
Used in Dye and Pigment Industry:
In the dye and pigment industry, Benzeneethanamine, N-Methyl-4-nitro-, is employed as a synthetic intermediate for the production of various dyes and pigments. Its ability to participate in different chemical reactions aids in the development of a wide array of colorants for various applications.
Used in Research and Development:
Benzeneethanamine, N-Methyl-4-nitro-, is used in research and development settings to explore its potential applications and reactions. Its reactivity and versatility make it an interesting subject for scientific investigations, potentially leading to the discovery of new compounds and applications.

Upstream product

• 124562-85-2 N-methyl-N-(2-(4-nitrophenyl)ethyl)trifluoroacetamide 
• 7697-37-2 nitric acid 
• 589-08-2 N-Methyl-N-phenethylamine 
• 67000-01-5 methyltertbutyl ether 
• 29968-78-3 2-(4-nitrophenyl)ethylamine monohydrochloride 
• 407-25-0 trifluoroacetic anhydride 
• 74-88-4 methyl iodide 
• 98245-61-5 N-methyl-2-(4-nitrophenyl)acetamide 
• 5339-26-4 (4-nitrophenyl)ethyl bromide 
• 74-89-5 methylamine 
• 24954-63-0 2,2,2-Trifluoro-N-(2-(4-nitrophenyl)ethyl)acetamide 
• 25566-63-6 methyl-phenethyl-amine; picrate 

Downstream Products

• 6406-74-2 4-(dimethylaminomethyl)aniline 
• 125174-41-6 Methyl-[2-(3-nitro-phenoxy)-ethyl]-[2-(4-nitro-phenyl)-ethyl]-amine 
• 125174-48-3 Methyl-[4-(4-nitro-phenoxy)-butyl]-[2-(4-nitro-phenyl)-ethyl]-amine 
• 125174-42-7 Methyl-[2-(2-nitro-phenoxy)-ethyl]-[2-(4-nitro-phenyl)-ethyl]-amine 
• 125174-46-1 Methyl-[2-(4-nitro-phenyl)-ethyl]-[3-(4-nitro-phenyl)-propyl]-amine 
• 115287-37-1 1-(4-nitrophenoxy)-2-ethane 
• 115256-40-1 2-[N-methyl-N-(4-nitrophenethyl)amino]-1-(4-nitrophenylthio)ethane 
• 125174-47-2 Methyl-[3-(4-nitro-phenoxy)-propyl]-[2-(4-nitro-phenyl)-ethyl]-amine 
• 115256-18-3 4-{2-[N-methyl-N-(4-nitrophenethyl)amino]ethoxy}benzamide 
• 125174-49-4 Methyl-[4-(4-nitro-phenyl)-butyl]-[2-(4-nitro-phenyl)-ethyl]-amine 
• 125174-37-0 3-(2-{Methyl-[2-(4-nitro-phenyl)-ethyl]-amino}-ethoxy)-benzamide 
• 125197-03-7 5-Methyl-2-(2-{methyl-[2-(4-nitro-phenyl)-ethyl]-amino}-ethoxy)-benzamide 
• 125174-39-2 2-[4-(2-{Methyl-[2-(4-nitro-phenyl)-ethyl]-amino}-ethoxy)-phenyl]-acetamide 
• 115256-26-3 N-methyl-4-{2-[N'-methyl-N'-(4-nitrophenethyl)amino]ethoxy}benzamide 

Relevant academic research and scientific papers

Iron-Catalyzed Intramolecular C—H Amidation of N-Benzoyloxyureas

A redox-neutral Fe-catalyzed intramolecular C—H amidation of N-benzoyloxyureas is described. This methodology employs a simple iron complex in situ generated from Fe(OTf)2 and bipyridine as the catalyst and N-benzoyloxyureas as the nitrene prec

Protein–ligand interaction-guided discovery of novel VEGFR-2 inhibitors

As an effective target in abnormal angiogenesis-related tumor treatment, VEGFR-2 has small-molecule inhibitors of various scaffolds being approved for treating diseases such as renal carcinoma, non-small cell lung cancer, etc. However, endogenous and acqu

METHODS OF USING SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS

Methods of using semi-synthetic glycopeptides of formula I-XIV having antibacterial activity are described.

1H-IMIDAZO[4,5-C]QUINOLINE DERIVATIVES IN THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES

The invention relates to the use of imidazoquinolines and salts thereof in the treatment of protein kinase diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases, imidazoquinolines for use in the treatment of protein kinase dependent diseases, a method of treatment against said diseases, comprising administering the imidazoquinolines to a warm-blooded animal, especially a human, pharmaceutical preparations comprising an imidazoquinoline, especially for the treatment of a protein kinase dependent disease, novel imidazoquinolines, and a process for the preparation of the novel imidazoquinolines.

(Phenylalkylaminoalkyloxy)-heteroaryl-compounds, processes and intermediates for their production and pharmaceutical compositions containing them

3-(Phenylalkylaminoalkylozy)-heteroaryl compounds having heart rate lowering and/or anti-ischemic effects, methods for their preparation and pharmaceutical compositions containing them are described. The compounds correspond to the general formula I STR1 or to the general formula XXXI STR2 in which the substituents have the meanings given the specification.

Studies on Ca2+ channel antagonists. A 2-diazo-3,3,3-trifluoropropionamide derivative related to verapamil as a potential photoaffinity probe.

2-(3,4-Dimethoxyphenyl)-2-isopropyl-5-[N-[4-(N-methyl-2-diazo- 3,3,3-trifluoropropionamido)phenethyl]methyl-amino]valeronitril e (3), a potential photoaffinity probe for Ca2+ channels related to verapamil (1), was prepared from N-methyl-4-nitrophenethylam